Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Fate Therapeutics (FATE) Institutional Ownership

Fate Therapeutics logo
$1.73 -0.03 (-1.42%)
Closing price 05/18/2026 04:00 PM Eastern
Extended Trading
$1.75 +0.02 (+1.39%)
As of 06:56 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Fate Therapeutics (NASDAQ:FATE)

Current
Institutional Ownership
Percentage
97.54%
Number of
Institutional Buyers
(last 12 months)
35
Total
Institutional Inflows
(last 12 months)
$8.69M
Number of
Institutional Sellers
(last 12 months)
30
Total
Institutional Outflows
(last 12 months)
$11.72M
Get FATE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Fate Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

FATE Institutional Buying and Selling by Quarter

Fate Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026Irenic Capital Management LP878,055$1.05M0.1%N/A0.753%
5/14/2026 Renaissance Technologies LLC2,974,683$3.57M0.0%+26.0%2.558%
5/14/2026 Bruce & Co. Inc.789,188$947K0.3%+8.2%0.679%
5/14/2026 Sei Investments Co.138,580$166K0.0%+104.9%0.119%
5/7/2026 Dimensional Fund Advisors LP883,790$1.06M0.0%-44.0%0.760%
4/28/2026 Abel Hall LLC36,748$44K0.0%N/A0.032%
4/20/2026 Assenagon Asset Management S.A.190,252$228K0.0%+28.0%0.164%
4/16/2026 SG Americas Securities LLC80,139$96K0.0%+105.9%0.069%
3/9/2026 Corient Private Wealth LLC29,830$29K0.0%N/A0.026%
2/23/2026 Virtu Financial LLC68,871$68K0.0%N/A0.060%
2/19/2026 Invesco Ltd.379,025$372K0.0%+20.4%0.329%
2/19/2026 Corient Private Wealth LLC29,830$29K0.0%N/A0.026%
2/18/2026 State of Tennessee Department of Treasury90,000$88K0.0%N/A0.078%
2/18/2026 XTX Topco Ltd364,738$358K0.0%-16.7%0.316%
2/18/2026 Vestal Point Capital LP1,725,000$1.70M0.1%-31.4%1.495%
2/18/2026 Tang Capital Management LLC1,167,773$1.15M0.1%-37.5%1.012%
2/18/2026 Quadrature Capital Ltd298,082$293K0.0%-21.0%0.258%
2/18/2026 Millennium Management LLC522,617$514K0.0%-45.8%0.453%
2/18/2026 Man Group plc261,172$257K0.0%+18.9%0.226%
2/18/2026 Bridgeway Capital Management LLC135,000$133K0.0%+35.0%0.117%
2/17/2026 Schonfeld Strategic Advisors LLC192,682$189K0.0%-64.6%0.167%
2/17/2026 AQR Capital Management LLC1,162,005$1.14M0.0%+2.7%1.007%
2/17/2026 Graham Capital Management L.P.195,579$192K0.0%-58.3%0.170%
2/16/2026 Barclays PLC308,542$303K0.0%+46.6%0.267%
2/13/2026 The Manufacturers Life Insurance Company 35,658$35K0.0%N/A0.031%
2/13/2026 State Street Corp2,265,217$2.23M0.0%-6.3%1.964%
2/13/2026 Ieq Capital LLC121,501$119K0.0%-11.7%0.105%
2/13/2026 Wells Fargo & Company MN172,283$169K0.0%+28.7%0.149%
2/12/2026 Jane Street Group LLC842,807$828K0.0%+36.7%0.731%
2/12/2026 HRT Financial LP48,544$47K0.0%-20.3%0.042%
2/12/2026 Commonwealth Equity Services LLC26,548$26K0.0%N/A0.023%
2/12/2026 Renaissance Technologies LLC2,360,881$2.32M0.0%+87.0%2.047%
2/12/2026 Dimensional Fund Advisors LP1,577,478$1.55M0.0%-24.7%1.368%
2/11/2026 Deutsche Bank AG91,679$90K0.0%-41.7%0.079%
2/10/2026 Goldman Sachs Group Inc.1,435,040$1.41M0.0%-3.5%1.244%
2/10/2026 Monaco Asset Management SAM830,000$816K0.1%+7.8%0.720%
2/9/2026 Geode Capital Management LLC2,468,348$2.43M0.0%-2.4%2.140%
2/3/2026 Privium Fund Management B.V.369,100$363K0.1%+10.8%0.320%
1/26/2026 CWM LLC51,789$51K0.0%-21.6%0.045%
1/9/2026 SG Americas Securities LLC38,913$38K0.0%+161.2%0.034%
Before you buy SpaceX shares, consider this alternative approach (Ad)

SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel

Discover the overlooked SpaceX IPO strategy before the June listing
11/17/2025 Jacobs Levy Equity Management Inc.814,639$1.03M0.0%-32.9%0.706%
11/17/2025 Susquehanna International Group LLP178,927$225K0.0%-53.8%0.155%
11/17/2025 Millennium Management LLC963,871$1.21M0.0%+9.6%0.836%
11/17/2025Bank of America Corp DE146,553$185K0.0%+20.0%0.127%
11/17/2025 Algert Global LLC106,920$135K0.0%N/A0.093%
11/17/2025 Ameriprise Financial Inc.261,671$330K0.0%-23.0%0.227%
11/14/2025 Schonfeld Strategic Advisors LLC544,587$686K0.0%-41.5%0.472%
11/14/2025 Man Group plc219,658$277K0.0%N/A0.190%
11/14/2025 Two Sigma Investments LP900,757$1.14M0.0%+294.4%0.781%
11/14/2025 Bridgeway Capital Management LLC100,000$126K0.0%+300.0%0.087%
11/13/2025 Bruce & Co. Inc.729,188$919K0.3%+69.9%0.632%
11/13/2025 BNP Paribas Financial Markets27,356$34K0.0%-90.5%0.024%
11/13/2025 Russell Investments Group Ltd.28,676$36K0.0%+73.1%0.025%
11/13/2025 Knott David M Jr365,000$460K0.2%N/A0.316%
11/12/2025 Dimensional Fund Advisors LP2,094,975$2.64M0.0%-14.1%1.817%
11/12/2025 Intech Investment Management LLC56,316$71K0.0%-23.3%0.049%
11/10/2025 Monaco Asset Management SAM770,000$970K0.1%+14.1%0.668%
11/7/2025 GSA Capital Partners LLP310,826$392K0.0%+21.1%0.270%
11/7/2025Vanguard Group Inc.8,798,491$11.09M0.0%+0.4%7.629%
11/5/2025 Savant Capital LLC35,968$45K0.0%+48.6%0.031%
11/4/2025 Privium Fund Management B.V.333,219$420K0.1%+200.0%0.289%
10/15/2025 CWM LLC66,093$83K0.0%+33.7%0.057%
10/9/2025 Voya Investment Management LLC22,502$28K0.0%-30.0%0.020%
10/7/2025 Assenagon Asset Management S.A.145,838$184K0.0%-31.3%0.126%
8/26/2025 Thrivent Financial for Lutherans37,116$41K0.0%-58.4%0.032%
8/16/2025 Headlands Technologies LLC49,556$56K0.0%N/A0.043%
8/15/2025 BNP Paribas Financial Markets287,412$322K0.0%-16.0%0.249%
8/15/2025 Bridgeway Capital Management LLC25,000$28K0.0%N/A0.022%
8/15/2025 Bruce & Co. Inc.429,188$481K0.2%-22.0%0.372%
8/15/2025Bank of America Corp DE122,130$137K0.0%-68.6%0.106%
8/15/2025 Ameriprise Financial Inc.339,714$380K0.0%-17.4%0.295%
8/14/2025 Jane Street Group LLC465,820$522K0.0%+631.4%0.406%
8/14/2025 Sei Investments Co.67,721$76K0.0%N/A0.059%
8/13/2025 Invesco Ltd.255,372$286K0.0%+19.6%0.223%
8/12/2025 XTX Topco Ltd432,328$484K0.0%-5.9%0.377%
8/12/2025 JPMorgan Chase & Co.58,574$66K0.0%-98.3%0.051%
8/8/2025 Geode Capital Management LLC2,429,167$2.72M0.0%+7.0%2.120%
8/7/2025 Monaco Asset Management SAM675,000$756K0.1%-41.3%0.589%
8/7/2025 Acadian Asset Management LLC2,459,954$2.75M0.0%-0.6%2.147%
8/6/2025 Savant Capital LLC24,205$27K0.0%N/A0.021%
7/25/2025 Vanguard Personalized Indexing Management LLC71,364$80K0.0%+65.6%0.062%
7/15/2025 Public Employees Retirement System of Ohio113,655$127K0.0%-30.1%0.099%
7/11/2025 Assenagon Asset Management S.A.212,342$238K0.0%-29.9%0.185%
5/29/2025Rhumbline Advisers150,248$119K0.0%-5.6%0.131%
5/21/2025Acadian Asset Management LLC2,473,565$1.95M0.0%+67.8%2.158%
5/19/2025Jane Street Group LLC63,691$50K0.0%+106.9%0.056%
5/16/2025Goldman Sachs Group Inc.2,458,974$1.94M0.0%-0.7%2.146%
5/16/2025Jacobs Levy Equity Management Inc.2,203,323$1.74M0.0%+38.8%1.923%
5/16/2025AQR Capital Management LLC585,025$462K0.0%+296.4%0.510%
5/15/2025Vestal Point Capital LP2,515,850$1.99M0.1%+2.1%2.195%
$30 stock to buy before Starlink goes public (WATCH NOW!) (Ad)

A little-known stock pick with money-doubling potential over the next year is revealed for free in the first three minutes of a new video. This company is a critical piece of Elon Musk's fast-growing Starlink technology. It could climb 100 percent or more over the next year as Elon brings Starlink public in what may be the biggest IPO in history. No credit card is required to get the ticker.tc pixel

Watch the free video to get the ticker today.
5/15/2025Caption Management LLC57,000$45K0.0%N/A0.050%
5/14/2025Comerica Bank82,024$65K0.0%+55,698.6%0.072%
5/14/2025Walleye Capital LLC72,286$57K0.0%-93.3%0.063%
5/14/2025Bruce & Co. Inc.550,000$434K0.1%+57.1%0.480%
5/13/2025Russell Investments Group Ltd.79,377$63K0.0%-11.6%0.069%
5/13/2025Callan Family Office LLC82,024$65K0.0%N/A0.072%
5/12/2025Nuveen LLC379,088$300K0.0%N/A0.331%
5/12/2025Invesco Ltd.213,503$169K0.0%+96.0%0.186%
5/9/2025Charles Schwab Investment Management Inc.703,825$556K0.0%-8.6%0.614%
5/9/2025Privium Fund Management B.V.109,026$86K0.0%+25.3%0.095%


FATE Institutional Ownership - Frequently Asked Questions

During the previous two years, 114 institutional investors and hedge funds held shares of Fate Therapeutics. The most heavily invested institutionals were Redmile Group LLC ($21.24M), Deerfield Management Company L.P. Series C ($11.66M), Vanguard Group Inc. ($11.09M), Baker BROS. Advisors LP ($5.38M), Renaissance Technologies LLC ($3.57M), Acadian Asset Management LLC ($2.75M), and D. E. Shaw & Co. Inc. ($2.54M).Learn more on Fate Therapeutics' institutional investors.

97.54% of Fate Therapeutics' stock is owned by institutional investors. Learn more on FATE's institutional investor holdings.

Of the 86 institutional investors that purchased Fate Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Renaissance Technologies LLC ($2.28M), Deerfield Management Company L.P. Series C ($1.37M), Dimensional Fund Advisors LP ($1.35M), Acadian Asset Management LLC ($1.29M), Monaco Asset Management SAM ($1.17M), Tang Capital Management LLC ($1.16M), and Walleye Capital LLC ($1.06M).

Institutional investors have bought a total of 7,864,521 shares in the last 24 months. This purchase volume represents approximately $8.69M in transactions.

Of the 30 institutional investors that sold Fate Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: JPMorgan Chase & Co. ($3.34M), Dimensional Fund Advisors LP ($1.55M), Vestal Point Capital LP ($790K), Schonfeld Strategic Advisors LLC ($738.13K), Tang Capital Management LLC ($700K), Monaco Asset Management SAM ($474.71K), and Millennium Management LLC ($441.25K).

Institutional investors have sold a total of 10,630,860 shares in the last 24 months. This volume of shares sold represents approximately $11.72M in transactions.



This page (NASDAQ:FATE) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners